Wednesday, July 8, 2009
Minimally Invasive Adiana Contraception Device Gets US Approval
Filed under: Ob/Gyn
, Reproductive Medicine
Hologic out of Bedford, Massachusetts won FDA approval for the Adiana® permanent contraception system. The device first delivers RF energy to provoke a minimal inflammation inside section of the fallopian tube. Next, the clinician has to place a tiny stopper to block the passage. After placement, tissue forms around the stopper and permanently prevents future pregnancies.
The Adiana permanent contraception procedure is minimally invasive, requires no incisions and can be performed in the comfort of the doctor's office using local anesthesia. Patients are normally able to return to work or resume their daily activities within one day. In contrast, traditional methods of permanent contraception, such as tubal ligation, require more invasive surgical procedures, usually are conducted in a hospital under general anesthesia and typically require four to five days of recovery. As a result, these more invasive surgical procedures can pose serious risk of complications, including anesthesia-related problems and damage to organs or blood vessels. There were approximately 70,000 female transcervical contraception procedures performed in the U.S. last year.1The Adiana procedure is indicated for women who desire permanent birth control by occlusion of the fallopian tubes. Ideal candidates include women who do not want children in the future and would like the peace of mind and convenience of permanent birth control. The procedure may also be an ideal solution for women who desire permanent birth control but are poor candidates for surgery.
Company video presenting the Adiana system:
Press release: FDA Approves Hologic's Adiana® Permanent Contraception System...
Product page: Adiana Permanent Contraception...
(0)
examples: <b>Bold</b> <i>Italic</i>
